These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 15272088

  • 1. New invMED1 element cis-activates human multidrug-related MDR1 and MVP genes, involving the LRP130 protein.
    Labialle S, Dayan G, Gayet L, Rigal D, Gambrelle J, Baggetto LG.
    Nucleic Acids Res; 2004; 32(13):3864-76. PubMed ID: 15272088
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene.
    Stein U, Bergmann S, Scheffer GL, Scheper RJ, Royer HD, Schlag PM, Walther W.
    Oncogene; 2005 May 19; 24(22):3606-18. PubMed ID: 15750632
    [Abstract] [Full Text] [Related]

  • 4. Phosphorylation of RNA helicase A by DNA-dependent protein kinase is indispensable for expression of the MDR1 gene product P-glycoprotein in multidrug-resistant human leukemia cells.
    Zhong X, Safa AR.
    Biochemistry; 2007 May 15; 46(19):5766-75. PubMed ID: 17441731
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs.
    Baker EK, Johnstone RW, Zalcberg JR, El-Osta A.
    Oncogene; 2005 Dec 01; 24(54):8061-75. PubMed ID: 16091741
    [Abstract] [Full Text] [Related]

  • 8. Transcription factor NF-Y regulates mdr1 expression through binding to inverted CCAAT sequence in drug-resistant human squamous carcinoma cells.
    Okamura H, Yoshida K, Sasaki E, Morimoto H, Haneji T.
    Int J Oncol; 2004 Oct 01; 25(4):1031-7. PubMed ID: 15375553
    [Abstract] [Full Text] [Related]

  • 9. Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein.
    Yamagishi N, Nakao R, Kondo R, Nishitsuji M, Saito Y, Kuga T, Hatayama T, Nakayama Y.
    Biochem Biophys Res Commun; 2014 Jun 13; 448(4):430-6. PubMed ID: 24796664
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Involvement of MyoD and PEA3 in regulation of transcription activity of MDR1 gene.
    Zhao Y, Liu J, Hong Q, Yang C, Chen L, Chen Y, Wang Q, Zhao K, Jin W.
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec 13; 42(12):900-7. PubMed ID: 20980337
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Significant transcriptional down-regulation of the human MDR1 gene by beta-naphthoflavone: a proposed hypothesis linking potent CYP gene induction to MDR1 inhibition.
    Nwankwo JO.
    Med Hypotheses; 2007 Dec 13; 68(3):661-9. PubMed ID: 17011724
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Establishment and characterization of new cellular lymphoma model expressing transgenic human MDR1.
    Findling-Kagan S, Sivan H, Ostrovsky O, Nagler A, Galski H.
    Leuk Res; 2005 Apr 13; 29(4):407-14. PubMed ID: 15725475
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The MDR1 downstream promoter contains sequence-specific binding sites for wild-type p53.
    Strauss BE, Shivakumar C, Deb SP, Deb S, Haas M.
    Biochem Biophys Res Commun; 1995 Dec 26; 217(3):825-31. PubMed ID: 8554604
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia.
    Comerford KM, Cummins EP, Taylor CT.
    Cancer Res; 2004 Dec 15; 64(24):9057-61. PubMed ID: 15604272
    [Abstract] [Full Text] [Related]

  • 20. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.
    Kaszubiak A, Holm PS, Lage H.
    Int J Oncol; 2007 Aug 15; 31(2):419-30. PubMed ID: 17611700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.